ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units

July 4, 1986

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

Cancer Programs Close Amid Gridlock

October 4, 2013

In Brief: NCI Names Rice To Head Frederick Center; NIAID Appoints Killen DAIDS Director

April 22, 1994

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006